Clinical Trial Update: Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ferumoxytol-enhanced MRI for detecting lymph node metastases in prostate, bladder, and kidney cancers; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Kidney Cancer
• Prostate Cancer

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-08-28